Jpmorgan Chase & CO Bioventus Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BVS
# of Institutions
142Shares Held
45.9MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$150 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$79.8 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$50 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$27.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$23.8 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $709M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...